search
Back to results

ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care

Primary Purpose

Psychomotor Agitation, Behavioral Disorder

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
ED-TREAT
Sponsored by
Yale University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Psychomotor Agitation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. adult (age≥18) patients presenting to the YNHH ED during the pilot trial period
  2. deemed to have a mild-moderate or high risk of agitation as determined by ED-TREAT
  3. do not require physical restraint orders <30 minutes of arrival
  4. with a score of "4" (quiet and awake; normal level of activity) on the Behavioral Activity Rating Scale
  5. have comfort with conversational English
  6. able to provide verbal consent.

Exclusion Criteria:

1. Presence of a restraint order <30 minutes of arrival and presence of a non-violent physical restraint order where indications are not due to agitation (e.g., for protecting intubation or life-preserving equipment)

Sites / Locations

  • Yale New Haven Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

ED-TREAT

Usual Care

Arm Description

EHR-embedded clinical decision support (CDS) tool designed to overcome the challenges to risk assessment and suggest pre-emptive use of behavioral techniques in the emergency setting.

Outcomes

Primary Outcome Measures

Proportion of visits adherent to protocol
Proportion of visits in the intervention arm that are adherent to >95% of the observational workflow checklist (primary outcome of fidelity)

Secondary Outcome Measures

System usability scale
Acceptability will be measured using a scale the System Usability Scale. The System Usability Scale is a widely used and effective survey composed of ten statements assessed on a 5-point Likert scale, with inter-item correlations of 0.69-0.75 and a reliability coefficient α of 0.91. The scale provides continuous data from 0-100 with scores >85 as indicative of excellent usability, and will be described using mean and standard deviation. The study will consider ED-TREAT to be acceptable if at least 90% of each clinician group give ratings >85.

Full Information

First Posted
June 30, 2021
Last Updated
September 5, 2023
Sponsor
Yale University
Collaborators
National Institute of Mental Health (NIMH)
search

1. Study Identification

Unique Protocol Identification Number
NCT04959279
Brief Title
ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care
Official Title
A Pilot Randomized Controlled Trial of ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
December 1, 2024 (Anticipated)
Primary Completion Date
September 15, 2025 (Anticipated)
Study Completion Date
June 1, 2026 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yale University
Collaborators
National Institute of Mental Health (NIMH)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The purpose of this study is to conduct a a pilot trial that tests the acceptability, fidelity, and feasibility of ED-TREAT.
Detailed Description
This study will be a pilot RCT that compares ED-TREAT to usual care. The scientific premise of the proposed project is that an innovative EHR-embedded clinical decision support (CDS) tool can overcome the challenges to risk assessment and suggest pre-emptive use of behavioral techniques in the emergency setting. This would help clinicians appropriately invest resources to improve the quality of care for at-risk patients regardless of ultimate medical or psychiatric diagnoses and prevent agitation from occurring. This pilot trial will (1) test the integrity of the study protocol in preparation for a future full-scale RCT, (2) evaluate randomization protocols, (3) estimate rates of recruitment and retention, (4) assess acceptability and fidelity of the intervention, and (5) determine if the proposed effect size is reasonable. This registered study is actually the third aim of a larger study where the tool will be developed and assessed using observational data and input from a steering committee in aims 1 and 2 prior to pilot testing.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Psychomotor Agitation, Behavioral Disorder

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
2:1 randomization and also recruit a higher proportion of high-risk patients in each arm
Masking
None (Open Label)
Allocation
Randomized
Enrollment
26 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
ED-TREAT
Arm Type
Experimental
Arm Description
EHR-embedded clinical decision support (CDS) tool designed to overcome the challenges to risk assessment and suggest pre-emptive use of behavioral techniques in the emergency setting.
Arm Title
Usual Care
Arm Type
No Intervention
Intervention Type
Other
Intervention Name(s)
ED-TREAT
Intervention Description
Patients will be assessed and treated based on a clinical decision support system.
Primary Outcome Measure Information:
Title
Proportion of visits adherent to protocol
Description
Proportion of visits in the intervention arm that are adherent to >95% of the observational workflow checklist (primary outcome of fidelity)
Time Frame
12 months
Secondary Outcome Measure Information:
Title
System usability scale
Description
Acceptability will be measured using a scale the System Usability Scale. The System Usability Scale is a widely used and effective survey composed of ten statements assessed on a 5-point Likert scale, with inter-item correlations of 0.69-0.75 and a reliability coefficient α of 0.91. The scale provides continuous data from 0-100 with scores >85 as indicative of excellent usability, and will be described using mean and standard deviation. The study will consider ED-TREAT to be acceptable if at least 90% of each clinician group give ratings >85.
Time Frame
Baseline, 15 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: adult (age≥18) patients presenting to the YNHH ED during the pilot trial period deemed to have a mild-moderate or high risk of agitation as determined by ED-TREAT do not require physical restraint orders <30 minutes of arrival with a score of "4" (quiet and awake; normal level of activity) on the Behavioral Activity Rating Scale have comfort with conversational English able to provide verbal consent. Exclusion Criteria: 1. Presence of a restraint order <30 minutes of arrival and presence of a non-violent physical restraint order where indications are not due to agitation (e.g., for protecting intubation or life-preserving equipment)
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ambrose H. Wong, MD, MSEd, MHS
Phone
(203) 737-2489
Email
ambrose.wong@yale.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Jessica Ray, PhD
Phone
(203) 737-2489
Email
Jessica.ray@yale.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ambrose H. Wong, (203) 737-2489
Organizational Affiliation
Yale University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Yale New Haven Hospital
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06510
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ambrose H. Wong, MD, MSEd, MHS
Phone
(203) 737-2489
Email
ambrose.wong@yale.edu
First Name & Middle Initial & Last Name & Degree
Ambrose H. Wong, MD, MSEd, MHS

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

ED-TREAT (Early Detection and Treatment to Reduce Events With Agitation Tool) Compared to Usual Care

We'll reach out to this number within 24 hrs